An Improved Standard of Care for the Treatment of Ear
Infections

Your Subtitle text
The EToscope – Device & Procedure
EntraTympanic, LLC is currently offering to accredited investors preferred stock with a minimum investment is $25,000 as part of a $3.5-5.0M Series A financing. Interested accredited investors are welcome to contact EntraTympanic’s President, Dr. George “Buzz” Kenney, at 617 504-0384 or GKenney@EntraTympanic.Com.

Instant Pain Relief without Systemic Antibiotics

EntraTympanic, LLC is currently offering to accredited investors preferred stock with a minimum investment is $25,000 as part of a $3.5-5.0M Series A financing. Interested accredited investors are welcome to contact EntraTympanic’s President, Dr. George “Buzz” Kenney, at 617 504-0384 or GKenney@EntraTympanic.Com.

The EToscope provides instant relief for extremely painful ear infections which are due to fluid accumulation and pressure in the middle ear, which also severely reduces the child’s ability to hear.  Over time, this diminished hearing can impair both speech and cognitive development. Shares of Series A Preferred Stock

Minimum investment per investor: $25,000

OFFERING PURSUANT TO NEW SEC REGULATION 506(C) UNDER THE JOBS ACT

OPEN ONLY TO “ACCREDITED INVESTORS”

EntraTympanic, LLC is taking advantage of new SEC regulations that enable “general solicitation” of investors to participate in a private placement of securities. Before the new regulations, such a private placement would not have been accessible to most accredited investors.



 
The EToscope™ is an otoscope-like device that allows physicians and nurses to: 
  • diagnose ear infections more accurately;
  • drain fluid safely from the middle ear, rapidly reducing pain and bacterial load;
  • deliver medication directly to the middle ear, thereby avoiding systemic antibiotics.

This minimaly invasive procedure provides safe in-office access to the middle ear via the tympanic membrane.

 
Device & Procudure

The EToscope is a proprietary otoscope-like device with the potential to provide an improved standard of care in terms of both improved diagnosis and treatment of ear infections. It is designed to fit snugly into the outer ear canal and thereby safely moves in unison with the child. It is also designed to be self-limiting in terms of depth of penetration (<0.5mm), thereby safely avoiding contact with the structures of the middle ear. The procedure takes only seconds to perform in the doctor's office and provides rapid pain relief and accelerates recovery from symptoms as well as eliminates the use of systemic antibiotics.

For more information about ear infections and their treatment, please visit our In The News page.  


Script embedded in HTML

Website Builder